The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(4-bromobenzylidene)-2,2-diphenylcyclopropanecarbohydrazide ID: ALA4757292
PubChem CID: 9624647
Max Phase: Preclinical
Molecular Formula: C23H19BrN2O
Molecular Weight: 419.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N/N=C/c1ccc(Br)cc1)C1CC1(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C23H19BrN2O/c24-20-13-11-17(12-14-20)16-25-26-22(27)21-15-23(21,18-7-3-1-4-8-18)19-9-5-2-6-10-19/h1-14,16,21H,15H2,(H,26,27)/b25-16+
Standard InChI Key: ZXQPNQVGAGPCET-PCLIKHOPSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
23.7991 -11.0151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0246 -10.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2244 -10.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8418 -10.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4332 -9.5179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9728 -9.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1734 -9.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6272 -9.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8858 -10.5037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6846 -10.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0056 -11.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7800 -11.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3499 -12.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1484 -12.3838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3702 -11.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5493 -10.6362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5489 -11.4534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2572 -10.2280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9647 -10.6370 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6726 -10.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3801 -10.6377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3756 -11.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0823 -11.8630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7912 -11.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7890 -10.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0818 -10.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4993 -11.8627 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 2 1 0
5 4 1 0
2 5 1 0
3 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 3 1 0
1 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 1 1 0
4 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 419.32Molecular Weight (Monoisotopic): 418.0681AlogP: 4.91#Rotatable Bonds: 5Polar Surface Area: 41.46Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.81CX Basic pKa: 1.71CX LogP: 5.51CX LogD: 5.51Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: -0.76
References 1. McNulty J,Babu Dokuburra C,D'Aiuto L,Demers M,McClain L,Piazza P,Williamson K,Zheng W,Nimgaonkar VL. (2020) Synthesis of non-nucleoside anti-viral cyclopropylcarboxacyl hydrazones and initial anti-HSV-1 structure-activity relationship studies., 30 (24): [PMID:32961320 ] [10.1016/j.bmcl.2020.127559 ]